Back to Search
FREDERIC REU, M.D.
M.D.
Medical Oncology Physician
NPI: 1750543963Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
35.091896(OH)
Research & Publications (6)
Overcoming resistance to interferon-induced apoptosis of renal carcinoma and melanoma cells by DNA demethylation.
PMID 16801630·J Clin Oncol·2006
7-preclinical
Expression of RASSF1A, an epigenetically silenced tumor suppressor, overcomes resistance to apoptosis induction by interferons.
PMID 16510600·Cancer Res·2006
8-other
Undifferentiated thyroglobulin-positive thyroid cancer 45 years after treatment for papillary primary.
PMID 16224416·Clin Adv Hematol Oncol·2003
5-case
Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL.
PMID 17653094·Oncogene·2008
8-other
Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
PMID 17622529·Ann Hematol·2007
8-other
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis.
PMID 15118763·Cell Death Differ·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9500 EUCLID AVE, SUITE RC25
CLEVELAND, OH 44195 - Phone
- (216) 444-2200
Quick Facts
- NPI
- 1750543963
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 6
Are you this provider?
Claim Your Profile